p15 (lnk4b) silencing leads to cell-cycle progression in both AML cell lines and in CD34+ primary AML cells [11] and supports AML transformation by Hoxa9/Meis1 in mice (Table 1) [12]. Here, HOXA9 is linked to acute myeloid leukemia.